2019
DOI: 10.1016/j.jphs.2018.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Haloperidol affects coupling between QT and RR intervals in guinea pig isolated heart

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 29 publications
0
3
0
Order By: Relevance
“…Detailed analysis of QT duration in rabbit protocols with drug-induced long-QT or short-QT syndrome indicated the possible effect of acute mechano-electrical function on long-QT syndrome–related arrhythmogenesis ( Nimani et al, 2021 ). Generally, this feature is a basic marker used in a wide range of proarrhythmic research studies, including those conducted in transgenic rabbit models ( Baczkó et al, 2020 ), larval zebrafish models ( Barrett et al, 2021 ), and guinea pig isolated heart models ( Vesely et al, 2019 ). So-called QT/RR coupling and—though rarely used—HRV analysis can be successfully evaluated in such studies, as previously shown in the context of haloperidol administration in isolated Sprague Dawley rat and guinea pig models ( Janousek et al, 2017 ; Vesely et al, 2019 ).…”
Section: Ecg Analysismentioning
confidence: 99%
See 1 more Smart Citation
“…Detailed analysis of QT duration in rabbit protocols with drug-induced long-QT or short-QT syndrome indicated the possible effect of acute mechano-electrical function on long-QT syndrome–related arrhythmogenesis ( Nimani et al, 2021 ). Generally, this feature is a basic marker used in a wide range of proarrhythmic research studies, including those conducted in transgenic rabbit models ( Baczkó et al, 2020 ), larval zebrafish models ( Barrett et al, 2021 ), and guinea pig isolated heart models ( Vesely et al, 2019 ). So-called QT/RR coupling and—though rarely used—HRV analysis can be successfully evaluated in such studies, as previously shown in the context of haloperidol administration in isolated Sprague Dawley rat and guinea pig models ( Janousek et al, 2017 ; Vesely et al, 2019 ).…”
Section: Ecg Analysismentioning
confidence: 99%
“…Generally, this feature is a basic marker used in a wide range of proarrhythmic research studies, including those conducted in transgenic rabbit models ( Baczkó et al, 2020 ), larval zebrafish models ( Barrett et al, 2021 ), and guinea pig isolated heart models ( Vesely et al, 2019 ). So-called QT/RR coupling and—though rarely used—HRV analysis can be successfully evaluated in such studies, as previously shown in the context of haloperidol administration in isolated Sprague Dawley rat and guinea pig models ( Janousek et al, 2017 ; Vesely et al, 2019 ). The prolonged QT duration was found in the methylazoxymethanol acetate rat model of schizophrenia, which has indicated the models’ applicability for investigating the risk factors of ventricular arrhythmias and sudden cardiac death in patients treated with antipsychotics drugs ( Stracina et al, 2016 ).…”
Section: Ecg Analysismentioning
confidence: 99%
“…Blocking I Kr channels QTc prolongation [26][27][28] Haloperidol [29][30][31][32] Ziprasidone [32,33] Moderate risk Amisulpride (oral)…”
Section: Chlorpromazinementioning
confidence: 99%
“…Blocking I Kr channels QTc prolongation [34,35] Clozapine [36,37] Flupentixol [38] Haloperidol (oral) [29][30][31][32] Olanzapine [26,39,40] Pimozide [32,40,41] Quetiapine [32,40,42] Risperidone [32,40] Thioridazine [28,32,40,43] Mesoridazine [32,33] Perphenazine [28] Trifluoperazine [28] Sertindole [40] Sulpiride [40] Low risk…”
Section: Chlorpromazinementioning
confidence: 99%
“…Flufenamic acid NSAID 14 0.137 ± 0.017 (EC50) Hypertension and congestive heart failure (Miyamori et al, 1985) 600 mg >350 (without First Pass Effect)* Haloperidol Antipsychotic 10 30 (TC) Prolongation of QT interval, torsades de pointes, sudden cardiac death (Meyer-Massetti et al, 2010;Fernandes et al, 2018;Vesely et al, 2019) (Basyigit et al, 2005;Lu et al, 2015;Okeahialam, 2015) 500 mg/day i.v. Prolongation of QT interval, torsades de pointes, bradycardia, asystole (Malizia et al, 1980;Danze and Langdorf, 1991;Luzza et al, 2006) 16.2 mg/L >60 18 (EC50) AV block, ventricular premature contraction and/or ventricular tachycardia (rats) (Lee et al, 1972(Lee et al, , 1974Lin et al, 1992) 1300 mg (65 kg human, 20 mg/kg i.v.…”
Section: >20*mentioning
confidence: 99%